This site is intended for Healthcare Professionals only.

COVID-19: PM announces extra £46m funding package to fight virus

Date:

Share post:

Prime Minister Boris Johnson today announced a £46 million funding package for urgent work to find a COVID-19 vaccine and develop a rapid test for the disease.

The announcement builds on the plan set out by the Prime Minister earlier this week to tackle the disease in the country.

This sum is in addition to the £30 million commitment that the UK has already made to the Coalition for Epidemic Preparedness Innovations (CEPI).

The latest funding package includes support for the World Health Organisation’s Flash Appeal and will also help vulnerable countries prepare for the spread of coronavirus in other ways.

It brings the UK’s total support to fight the virus internationally to £91 million and the investment into COVID-19 vaccine research to £65 million.

Prime Minister Boris Johnson said: “Keeping the British people safe is my number one priority, and that’s why I’ve set out our four-part plan to contain, delay, mitigate and research coronavirus.”

We are ensuring the country is prepared for the current outbreak, guided by the science at every stage. But we also need to invest now in researching the vaccines that could help prevent future outbreaks.”

The Prime Minister has visited the Mologic Laboratory in the Bedford technology Park,  where British scientists are working on ways to diagnose coronavirus.

“I’m very proud that UK experts – backed by government funding – are on the front line of global efforts to do just that,” he said.

Supported by UK funding, eight possible coronavirus vaccines are currently under development and efforts are being made to get any viable vaccines from sequencing of the virus to clinical testing in under a year. Governments around the world could then work with pharmaceutical companies to get vaccines into production and use.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Haleon to close Maidenhead manufacturing site affecting 435 jobs

Despite the closure, Haleon will retain its presence in the UK with corporate offices in Weybridge and London Haleon,...

UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition

Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects   British pharmacies and slimming...

MHRA says many online pharmacies are ‘unregulated’,’ illegal’, or ‘fraudulent’

MHRA's latest initiative aims to empower consumers in the fight against online pharmacy frauds The Medicines and Healthcare products...

MHRA outlines strategic approach to AI regulation in healthcare for patient safety

MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity In a...